Download
sickle cell pain management in the emergency department n.
Skip this Video
Loading SlideShow in 5 Seconds..
Sickle Cell Pain Management in the Emergency Department PowerPoint Presentation
Download Presentation
Sickle Cell Pain Management in the Emergency Department

Sickle Cell Pain Management in the Emergency Department

257 Vues Download Presentation
Télécharger la présentation

Sickle Cell Pain Management in the Emergency Department

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. LOYOLA UNIVERSITY HEALTH SYSTEM Loyola University Chicago Sickle Cell Pain Management in the Emergency Department B. Probst, MD; J. Williams, RN; D. Speed, RN, MSN; M. Cichon, DO; C. Jackson, MD; M. Pearlman, MS4

  2. Opportunity to Improve: Pain assessment Treatment of pain Disposition Desired Outcome: Consistent pain assessment & documentation Standardize treatment Expedite timely disposition to home or admission to hospital Sickle cell patients in the ED: small volume, LARGE PROBLEMS

  3. Opportunity Knocks • Subjective nature of pain • Opioid-tolerant patients • Little use of adjunctive agents • Timeliness of assessment and treatment

  4. Solutions Implemented • Convened a multi-disciplinary team • General Medicine, Anesthesia Pain Service, Social Work, ED Physicians & Nurses • Developed and implemented a focused guideline • Educated ED caregivers & patients • Collaborated with General Medicine initiative for inpatient sickle cell management

  5. Progress to Date • Guideline implemented July, 2002 • Minor adjustments made to guideline after feedback from Caregivers • Identified and collected data measures: • Documentation of VAS • Analgesic usage • Adjunct usage • Time-to-treatment • Length-of-stay

  6. Pain Assessment • VAS documentation improved at all time intervals • Reassessment of pain after medication administration is an area that offers an opportunity for improvement

  7. Pain Medications • Use of Dilaudid has increased since guideline implementation • Demerol utilization has decreased

  8. Time to Treatment & LOS • Time to treatment decreased from 80 to 57 minutes • ED length of stay has decreased from 271 minutes to 232 minutes

  9. Adjunctive Effect of Toradol • Patients that received Toradol, in addition to opioid analgesics, were more likely to be discharged home from the ED, than admitted to the hospital

  10. Conclusions • Focused guideline usage has improved care for sickle cell patients in the ED: • Improved pain assessment • Decreased time to treatment & length-of-stay • Decreased demerol usage • Increased discharge to home with toradol adjunct • Sickle Cell Guideline has proven to be a useful resource for physicians managing pain in patients with Sickle Cell disease.

  11. Next Steps • Continue utilization of guideline • Further education of staff on reassessment after pain medications and treatment of pain • Increase utilization of toradol • Refine guideline based on feedback • Ongoing review of compliance to guideline